Research Progress of Combination Therapy of Apatinib on Tumor

Research Progress of Combination Therapy of Apatinib on Tumor

Angiogenesis plays an important role in tumor growth and metastasis, and vascular endothelial growth factor receptor 2 (VEGFR2) is a key regulatory factor in the process of angiogenesis. Apatinib mesylate is a small molecule tyrosine kinase inhibitor developed over ten years in China. At present, ap...

Full description

Bibliographic Details
Main Authors: WU Shan, HUA Zhan, LI Jianchen, ZHOU Jianjun, WANG Zai
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2019-03-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
apatinib
vegfr2
combination therapy
efficacy
mechanism
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2019.18.1059.htm

Similar Items

Similar Items